Indonesia halts use of AstraZeneca vaccine batch for toxicity tests

JAKARTA: Indonesia has temporarily suspended the use and distribution of an Oxford-AstraZeneca coronavirus disease (COVID-19) vaccine batch pending sterility and toxicity tests by the Drug and Food Monitoring Agency (BPOM), the Health Ministry said on Sunday.
The ministry announced the move following advice from the National Commission on Post-Immunization Accidents to carry out the tests.
It follows the death of a 22-year-old man in East Jakarta, who suffered from a high fever and eventually died after receiving his first jab earlier this month.
Siti Nadia Tarmizi, a Health Ministry spokesperson for the national COVID-19 vaccination program, said that the suspension of the batch would not deter the use of other AstraZeneca batches in the jabs program, which began four months ago.

Related Keywords

Indonesia ,East Java ,Jawa Timur ,Bali ,Jakarta ,Jakarta Raya ,Indonesian ,Siti Nadia Tarmizi ,Pandji Dhewantara ,Hindra Irawan Satari ,National Commission On ,Astrazeneca ,Food Monitoring Agency ,Indonesian Chamber ,World Health Organization ,Health Ministry ,Post Immunization Accidents ,East Jakarta ,Nadia Tarmizi ,North Sulawesi ,Dwi Ardyanto ,Arab News ,இந்தோனேசியா ,கிழக்கு ஜாவா ,ஜவ டைமூர் ,பாலி ,ஜகார்த்தா ,ஜகார்த்தா ராய ,இந்தோனேசிய ,தேசிய தரகு ஆன் ,இந்தோனேசிய அறை ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,ஆரோக்கியம் அமைச்சகம் ,போஸ்ட் நோய்த்தடுப்பு விபத்துக்கள் ,கிழக்கு ஜகார்த்தா ,அரபு செய்தி ,